Background: The increasing number of chronic obstructive pulmonary disease (COPD) incidence has led to a great negative impact on older people's lives. This chronic disease was a critical and independent risk factor for cognitive function impairment in the elderly with mild cognitive impairment as a frequent feature. This systematic review aimed to examine the risk of developing cognitive impairment in COPD. Methods: A structured search of the literature was conducted using the Preferred Reporting Items for Systematic Reviews and Meta-analyses statement guideline, with a pre-determined search strategy starting from study identification, title and abstract screening, eligibility assessment, and inclusion of relevant study. The search was conducted in PubMed and MEDLINE via EBSCOhost, with restriction to human studies. The studies from inception until January 12, 2021. Results: Five original articles were included. Most studies found that patients with COPD had a higher chance of developing cognitive impairment, especially when patients were followed up for more than 5 years. We discovered that the risk of cognitive impairment seemed to be correlated with the length of time spent following the participants, with the highest risk of cognitive impairment being identified in those who had the longest observation period. It is critical to conduct cognitive screening from the time a diagnosis of COPD is obtained and on a continuing basis in order to recognize and treat these individuals appropriately. Conclusion: There is a potential association between COPD and mild cognitive impairment. We encourage more studies to be done with higher sensitivity and specificity cognitive screening tools in the future to build better evidence and qualify to be analyzed quantitatively with meta-analysis.
Current primary intracerebral hemorrhage (ICH) treatments focus on limiting hematoma volume by lowering blood pressure, reversing anticoagulation, or hematoma evacuation. Nevertheless, there is no effective strategy to protect the brain from secondary injury due to ICH. Excess heme and iron as by-products of lysing clots in ICH might contribute to this secondary injury by triggering perihematomal edema. We present a clinical situation of an ICH case where iron-chelating therapy might be beneficial, as supported by scientific evidence. We looked through four databases (Pubmed, Cochrane, Embase, and Google Scholar) to find studies assessing the efficacy of iron-chelating therapy in ICH patients. Validity, importance, and applicability (VIA) of the included articles were appraised using worksheets from the Oxford Centre for Evidence-Based Medicine. Two out of five eligible studies were valid, important, and applicable to our patient. Both studies showed the positive effects of iron-chelating therapy on neurological outcome, as measured by National Institutes of Health Stroke Scale (NIHSS) score and modified Rankin Score (mRS). The beneficial effects of deferoxamine were demonstrated within the moderate volume (10–30 mL) subgroup, with a positive relative risk reduction (RRR) and low number needed to treat (six persons). Based on our appraisal, we considered iron-chelating therapy as an additional therapy for ICH patients, given its benefits and adverse effects. More specific studies using a larger sample size, focusing on moderate-volume ICH, and using standardized neurological outcomes are encouraged.
Cerebral ischemia is among the most common type of stroke seen in patient. Regeneration of death neurons remains questionable. Human umbilical cord blood mononuclear cell (cbMNC) is one of the treatment options for ischemia stroke through their various advantages; availability, pluripotency, and immaturity. One group of healthy rats and three groups (n=6 per group) of male Wistar rats undergone permanent middle cerebral artery occlusion (MCAO). Rats were allowed to recover for 7 days before intraarterial and intravenous injection of 1 × 106 cells/kg of human cbMNC. Behavioral tests were performed before the MCAO, 1 week after MCAO, and at 3, 9, and 14 days after cbMNC injection. Brain infarct area and neurons in hippocampus were evaluated. Spontaneous activity was much significantly improved compared with the placebo group (p<0.05). Comparing the neuron cells in hippocampus, intraarterial and intravenous have more changes in neurons morphology. No effect of cbMNC implantation in decreasing infarct area. Safety of xenogenic was confirmed by this study when the dosage of 1 × 106 cells/kg was used and showed their beneficial effects
Background The Kuesioner Pra Skrining Perkembangan/DPsQ (Developmental Pre-screening Questionnaire/DPsQ) is a series of questions and instructions used as a developmental screening tool for children aged 3 months to 6 years. However, the DPsQ cannot fully detect the soft signs of future neurological disorders. However, the retained primitive reflex assessment as an adjunct to the DPsQ may be useful for such detection. Objective To determine whether assessing for retained primitive reflexes can add to the usefulness of DPsQ as a neurodevelopmental screen in children aged 1 to 5 years. Methods This cross-sectional study included children aged 1-5 years. Developmental screening was done using the DPsQ and retained primitive reflex assessment was performed using the Institute for Neuro-Physiological Psychology (INPP) screening and scoring guideline. Results Of 46 subjects, 56.8% of children with normal DPsQ scores had not retained primitive reflexes, while 88.9% of children with suspect DPsQ score had retained primitive reflexes. Hence, children with suspect DPsQ score had a 10.5 times higher chance of retaining primitive reflexes (OR 10.50; 95%CI 1.19 to 92.73; P=0.034). Furthermore, 66.7-77.8% of children with suspect DPsQ score had retained the Moro reflex, asymmetrical tonic neck reflex (ATNR), and symmetrical tonic neck reflex (STNR). Neither gender nor age were significantly associated with either suspect DPsQ score or the presence of retained primitive reflexes. Conclusion The DPsQ results correlate to integration of primitive reflexes, with 10.50 greater odds of children with ‘suspect’ DPsQ scores to have retained primitive reflexes. As such, retained primitive reflexes is not useful as a primary screen for future neurological problems. However, a high percentage of children (43.2%) with normal DPsQ scores also have retained primitive reflexes.